Last10K.com

Abvc Biopharma, Inc. (ABVC) SEC Filing 10-Q Quarterly Report for the period ending Thursday, September 30, 2021

SEC Filings

ABVC Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ABVC Annual Reports

ABVC Quarterly Reports

ABVC Corporate News

ABVC Registration of Securities

American Brivision

HISTORY TOOLS
CIK: 743532 Ticker: ABVC
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2021
Nov. 12, 2021
Document Information Line Items  
Entity Registrant NameABVCBioPharma, Inc. 
Trading SymbolABVC 
Document Type10-Q 
Current Fiscal Year End Date--12-31 
Entity Common Stock, Shares Outstanding 28,609,388
Amendment Flagfalse 
Entity Central Index Key0001173313 
Entity Current Reporting StatusYes 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateSep. 30, 2021 
Document Fiscal Year Focus2021 
Document Fiscal Period FocusQ3 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number001-40700 
Entity Incorporation, State or Country CodeNV 
Entity Tax Identification Number26-0014658 
Entity Address, Address Line One44370Old Warm Springs Blvd 
Entity Address, City or TownFremont 
Entity Address, CountryCA 
Entity Address, Postal Zip Code94538 
City Area Code(510) 
Local Phone Number668-0881 
Title of 12(b) SecurityCommon Stock, par value $0.001 per share 
Security Exchange NameNASDAQ 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Brivision.

Continue

Assess how American Brivision's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Expense
Shares
Product
Geography
Dividend
Income
Cash Flow
Debt
Other
Inside American Brivision's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Operations And Comprehensive Loss (Unaudited)
Consolidated Statements Of Stockholders' Equity (Deficit) (Unaudited)
Accounting Policies, By Policy (Policies)
Bank Loans
Bank Loans (Details)
Bank Loans (Details) - Schedule Of Short-Term Bank Loan
Bank Loans (Tables)
Business Combination
Business Combination (Details)
Business Combination (Details) - Schedule Of Assets Acquired And Liabilities Assumed Based On Fair Value
Business Combination (Tables)
Collaborative Agreements
Collaborative Agreements (Details)
Convertible Notes Payable
Convertible Notes Payable (Details)
Equity
Equity (Details)
Equity (Details) - Schedule Of Converted Amount Of Debt And Shares
Equity (Tables)
Inventory
Inventory (Details) - Schedule Of Inventory
Inventory (Tables)
Lease
Lease (Details) - Schedule Of Minimum Future Annual Payments Under Non-Cancellable Leases
Lease (Details) - Schedule Of Operating Lease Arrangements
Lease (Details) - Schedule Of Supplemental Information Related To Operating Leases
Lease (Tables)
Long-Term Investments
Long-Term Investments (Details)
Long-Term Investments (Details) - Schedule Of Balance Sheets
Long-Term Investments (Details) - Schedule Of Equity Investments
Long-Term Investments (Details) - Schedule Of Extent The Investee Relies
Long-Term Investments (Details) - Schedule Of Long-Term Investment
Long-Term Investments (Details) - Schedule Of Ownership Percentages Of Investee
Long-Term Investments (Details) - Schedule Of Statements Of Operation
Long-Term Investments (Tables)
Loss Per Share
Loss Per Share (Details) - Schedule Of Loss Per Share
Loss Per Share (Tables)
Notes Payable
Notes Payable (Details)
Organization And Description Of Business
Organization And Description Of Business (Details)
Paycheck Protection Program Loan Payable
Paycheck Protection Program Loan Payable (Details)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Details) - Schedule Of Property And Equipment
Property And Equipment (Tables)
Related Parties Transactions
Related Parties Transactions (Details)
Related Parties Transactions (Details) - Schedule Of Amount Due From Related Parties
Related Parties Transactions (Details) - Schedule Of Amount Due To Related Parties
Related Parties Transactions (Details) - Schedule Of Amount Due To Related Parties
Related Parties Transactions (Details) - Schedule Of Related Party Transactions
Related Parties Transactions (Tables)
Short-Term Loan
Short-Term Loan (Details)
Stock Options
Stock Options (Details)
Stock Options (Details) - Schedule Of Fair Value Of Stock Options Granted
Stock Options (Details) - Schedule Of Options Issued And Outstanding
Stock Options (Tables)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Details) - Schedule Of Property And Equipment
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Exhibit 32.2: Certification
Ticker: ABVC
CIK: 1173313
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-21-059317
Submitted to the SEC: Mon Nov 15 2021 4:02:01 PM EST
Accepted by the SEC: Mon Nov 15 2021
Period: Thursday, September 30, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/abvc/0001213900-21-059317.htm